TACE and sorafenib: A good marriage? Journal Article


Author: Abou-Alfa, G. K.
Article Title: TACE and sorafenib: A good marriage?
Keywords: vasculotropin; cancer survival; treatment outcome; treatment response; sorafenib; bevacizumab; cisplatin; doxorubicin; erlotinib; fluorouracil; interferon; placebo; sunitinib; advanced cancer; cancer combination chemotherapy; cancer growth; chemoembolization; drug efficacy; drug safety; liver cell carcinoma; liver function; liver transplantation; treatment duration; unspecified side effect; carcinoma, hepatocellular; liver neoplasms; cancer adjuvant therapy; progression free survival; multiple cycle treatment; tumor volume; antineoplastic combined chemotherapy protocols; editorial; angiogenesis; retrospective study; cancer mortality; liver failure; antiangiogenic therapy; upregulation; inoperable cancer; cancer control; hypoxia inducible factor 1alpha; phase 2 clinical trial (topic); meta analysis (topic); phase 3 clinical trial (topic); tumor necrosis; gastrointestinal tumor; chemoembolization, therapeutic; invasive procedure
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 30
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-10-20
Start Page: 3949
End Page: 3952
Language: English
DOI: 10.1200/jco.2011.37.9651
PROVIDER: scopus
PUBMED: 21911718
DOI/URL:
Notes: --- - "Export Date: 9 December 2011" - "CODEN: JCOND" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    570 Abou-Alfa